vs
美盛公司（MOS）与Solventum（SOLV）财务数据对比。点击上方公司名可切换其他公司
美盛公司的季度营收约是Solventum的1.5倍（$3.0B vs $2.0B），Solventum净利率更高（3.2% vs -17.5%，领先20.6%），美盛公司同比增速更快（5.6% vs -3.7%），Solventum自由现金流更多（$32.0M vs $-405.7M），过去两年美盛公司的营收复合增速更高（5.3% vs -0.4%）
美盛公司（The Mosaic Company）是总部位于美国佛罗里达州坦帕的化工企业，主营磷矿、钾矿开采及尿素采集，依托多元国际分销网络和旗下肥料业务板块生产销售农用肥料，是美国规模最大的钾肥、磷肥生产商。
Solventum是一家总部位于美国的医疗健康企业，于2024年4月1日正式从全球知名多元化工业集团3M分拆后独立运营，继承了原3M旗下医疗板块的技术积累与业务资源，面向全球市场提供专业医疗相关产品及服务。
MOS vs SOLV — 直观对比
营收规模更大
MOS
是对方的1.5倍
$2.0B
营收增速更快
MOS
高出9.3%
-3.7%
净利率更高
SOLV
高出20.6%
-17.5%
自由现金流更多
SOLV
多$437.7M
$-405.7M
两年增速更快
MOS
近两年复合增速
-0.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $3.0B | $2.0B |
| 净利润 | $-519.5M | $63.0M |
| 毛利率 | 11.5% | 51.4% |
| 营业利润率 | -3.4% | 6.3% |
| 净利率 | -17.5% | 3.2% |
| 营收同比 | 5.6% | -3.7% |
| 净利润同比 | -407.4% | 103.2% |
| 每股收益（稀释后） | $-1.63 | $0.37 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MOSSOLV
| Q4 25 | $3.0B | $2.0B | ||
| Q3 25 | $3.5B | $2.1B | ||
| Q2 25 | $3.0B | $2.2B | ||
| Q1 25 | $2.6B | $2.1B | ||
| Q4 24 | $2.8B | $2.1B | ||
| Q3 24 | $2.8B | $2.1B | ||
| Q2 24 | $2.8B | $2.1B | ||
| Q1 24 | $2.7B | $2.0B |
净利润MOSSOLV
| Q4 25 | $-519.5M | $63.0M | ||
| Q3 25 | $411.4M | $1.3B | ||
| Q2 25 | $410.7M | $90.0M | ||
| Q1 25 | $238.1M | $137.0M | ||
| Q4 24 | $169.0M | $31.0M | ||
| Q3 24 | $122.2M | $122.0M | ||
| Q2 24 | $-161.5M | $89.0M | ||
| Q1 24 | $45.2M | $237.0M |
毛利率MOSSOLV
| Q4 25 | 11.5% | 51.4% | ||
| Q3 25 | 16.0% | 54.2% | ||
| Q2 25 | 17.3% | 54.4% | ||
| Q1 25 | 18.6% | 53.8% | ||
| Q4 24 | 10.7% | 53.9% | ||
| Q3 24 | 14.8% | 56.0% | ||
| Q2 24 | 14.0% | 54.6% | ||
| Q1 24 | 14.9% | 58.1% |
营业利润率MOSSOLV
| Q4 25 | -3.4% | 6.3% | ||
| Q3 25 | 9.8% | 80.6% | ||
| Q2 25 | 8.1% | 9.9% | ||
| Q1 25 | 12.9% | 7.3% | ||
| Q4 24 | 3.5% | 6.6% | ||
| Q3 24 | 4.1% | 13.2% | ||
| Q2 24 | 8.3% | 11.7% | ||
| Q1 24 | 6.5% | 18.9% |
净利率MOSSOLV
| Q4 25 | -17.5% | 3.2% | ||
| Q3 25 | 11.9% | 60.4% | ||
| Q2 25 | 13.7% | 4.2% | ||
| Q1 25 | 9.1% | 6.6% | ||
| Q4 24 | 6.0% | 1.5% | ||
| Q3 24 | 4.3% | 5.9% | ||
| Q2 24 | -5.7% | 4.3% | ||
| Q1 24 | 1.7% | 11.8% |
每股收益（稀释后）MOSSOLV
| Q4 25 | $-1.63 | $0.37 | ||
| Q3 25 | $1.29 | $7.22 | ||
| Q2 25 | $1.29 | $0.51 | ||
| Q1 25 | $0.75 | $0.78 | ||
| Q4 24 | $0.53 | $0.18 | ||
| Q3 24 | $0.38 | $0.70 | ||
| Q2 24 | $-0.50 | $0.51 | ||
| Q1 24 | $0.14 | $1.37 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $276.6M | $878.0M |
| 总债务越低越好 | $4.3B | $5.0B |
| 股东权益账面价值 | $12.1B | $5.0B |
| 总资产 | $24.5B | $14.3B |
| 负债/权益比越低杠杆越低 | 0.35× | 1.00× |
8季度趋势，按日历期对齐
现金及短期投资MOSSOLV
| Q4 25 | $276.6M | $878.0M | ||
| Q3 25 | $153.3M | $1.6B | ||
| Q2 25 | $286.2M | $492.0M | ||
| Q1 25 | $259.2M | $534.0M | ||
| Q4 24 | $272.8M | $762.0M | ||
| Q3 24 | $301.6M | $772.0M | ||
| Q2 24 | $322.0M | $897.0M | ||
| Q1 24 | $336.7M | $996.0M |
总债务MOSSOLV
| Q4 25 | $4.3B | $5.0B | ||
| Q3 25 | $3.4B | $5.1B | ||
| Q2 25 | $3.3B | $7.8B | ||
| Q1 25 | $3.3B | $7.9B | ||
| Q4 24 | $3.3B | $8.0B | ||
| Q3 24 | $3.2B | $8.1B | ||
| Q2 24 | $3.2B | $8.3B | ||
| Q1 24 | $3.2B | $8.3B |
股东权益MOSSOLV
| Q4 25 | $12.1B | $5.0B | ||
| Q3 25 | $12.8B | $5.0B | ||
| Q2 25 | $12.4B | $3.6B | ||
| Q1 25 | $11.8B | $3.3B | ||
| Q4 24 | $11.5B | $3.0B | ||
| Q3 24 | $11.8B | $3.2B | ||
| Q2 24 | $11.7B | $2.9B | ||
| Q1 24 | $12.0B | $3.9B |
总资产MOSSOLV
| Q4 25 | $24.5B | $14.3B | ||
| Q3 25 | $24.7B | $14.0B | ||
| Q2 25 | $24.3B | $15.1B | ||
| Q1 25 | $23.2B | $14.5B | ||
| Q4 24 | $22.9B | $14.5B | ||
| Q3 24 | $23.3B | $14.7B | ||
| Q2 24 | $22.6B | $14.6B | ||
| Q1 24 | $22.9B | $14.7B |
负债/权益比MOSSOLV
| Q4 25 | 0.35× | 1.00× | ||
| Q3 25 | 0.26× | 1.03× | ||
| Q2 25 | 0.27× | 2.14× | ||
| Q1 25 | 0.28× | 2.43× | ||
| Q4 24 | 0.29× | 2.71× | ||
| Q3 24 | 0.27× | 2.54× | ||
| Q2 24 | 0.27× | 2.90× | ||
| Q1 24 | 0.27× | 2.16× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-56.1M | $95.0M |
| 自由现金流经营现金流 - 资本支出 | $-405.7M | $32.0M |
| 自由现金流率自由现金流/营收 | -13.6% | 1.6% |
| 资本支出强度资本支出/营收 | 11.8% | 3.2% |
| 现金转化率经营现金流/净利润 | — | 1.51× |
| 过去12个月自由现金流最近4个季度 | $-534.6M | $-10.0M |
8季度趋势，按日历期对齐
经营现金流MOSSOLV
| Q4 25 | $-56.1M | $95.0M | ||
| Q3 25 | $228.5M | $76.0M | ||
| Q2 25 | $609.5M | $169.0M | ||
| Q1 25 | $42.9M | $29.0M | ||
| Q4 24 | $219.3M | $219.0M | ||
| Q3 24 | $312.9M | $169.0M | ||
| Q2 24 | $847.0M | $355.0M | ||
| Q1 24 | $-80.0M | $442.0M |
自由现金流MOSSOLV
| Q4 25 | $-405.7M | $32.0M | ||
| Q3 25 | $-135.9M | $-21.0M | ||
| Q2 25 | $304.9M | $59.0M | ||
| Q1 25 | $-297.9M | $-80.0M | ||
| Q4 24 | $-74.8M | $92.0M | ||
| Q3 24 | $72.1M | $76.0M | ||
| Q2 24 | $513.1M | $297.0M | ||
| Q1 24 | $-463.0M | $340.0M |
自由现金流率MOSSOLV
| Q4 25 | -13.6% | 1.6% | ||
| Q3 25 | -3.9% | -1.0% | ||
| Q2 25 | 10.1% | 2.7% | ||
| Q1 25 | -11.4% | -3.9% | ||
| Q4 24 | -2.7% | 4.4% | ||
| Q3 24 | 2.6% | 3.7% | ||
| Q2 24 | 18.2% | 14.3% | ||
| Q1 24 | -17.3% | 16.9% |
资本支出强度MOSSOLV
| Q4 25 | 11.8% | 3.2% | ||
| Q3 25 | 10.6% | 4.6% | ||
| Q2 25 | 10.1% | 5.1% | ||
| Q1 25 | 13.0% | 5.3% | ||
| Q4 24 | 10.4% | 6.1% | ||
| Q3 24 | 8.6% | 4.5% | ||
| Q2 24 | 11.9% | 2.8% | ||
| Q1 24 | 14.3% | 5.1% |
现金转化率MOSSOLV
| Q4 25 | — | 1.51× | ||
| Q3 25 | 0.56× | 0.06× | ||
| Q2 25 | 1.48× | 1.88× | ||
| Q1 25 | 0.18× | 0.21× | ||
| Q4 24 | 1.30× | 7.06× | ||
| Q3 24 | 2.56× | 1.39× | ||
| Q2 24 | — | 3.99× | ||
| Q1 24 | -1.77× | 1.86× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MOS
暂无分部数据
SOLV
| Infection Prevention And Surgical Solutions | $752.0M | 38% |
| Cost Of Software And Rentals | $508.0M | 25% |
| Health Information Systems Segment | $347.0M | 17% |
| Dental Solutions Segment | $343.0M | 17% |
| Related Party | $14.0M | 1% |
